PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15664442-6 2005 Subsequently, an autoimmune syndrome developed which shared certain features with the syndrome induced by inorganic mercury in H-2(s) mice, including antibodies targeting the 34 kDa nucleolar protein fibrillarin, increased expression of IL-4 mRNA, increase of Th2-type of immunoglobulins (IgE and IgG1), and increased MHC class II expression on B-cells. Mercury 116-123 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 297-301 21793797-7 2011 Examination of IFNgamma, IL-4, and IL-2 in exposed skin, draining lymph nodes, and spleen following mercury exposure showed reduced IL-4 in the spleen and skin in B2m-deficient mice, consistent with the lower IgG1 anti-chromatin levels, and reduced IFNgamma expression in the skin. Mercury 100-107 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 209-213 17015760-1 2006 In certain strains of mice, subtoxic doses of HgCl2 (mercuric chloride; mercury) induce a complex autoimmune condition characterized by the production of antinucleolar IgG Abs, lymphoproliferation, increased serum levels of IgG1/IgE Abs, and deposition of renal immune complexes. Mercury 72-79 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 224-228 9764596-7 1998 While mercury-treated IL-4(-/-) H-2S mice had virtually no detectable serum IgG1 or IgE, and very low levels of IgG1 ANoA, these mice had levels of IgG2a and IgG2b class ANoA comparable to mercury-treated IL-4+ H-2S mice, indicating that IL-4 is not required for the ANoA response in mercury-induced autoimmunity. Mercury 6-13 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 112-116 12874254-1 2003 After exposure to subtoxic doses of heavy metals such as mercury, H-2(s) mice develop an autoimmune syndrome consisting of the rapid production of IgG autoantibodies that are highly specific for nucleolar autoantigens and a polyclonal increase in serum IgG1 and IgE. Mercury 57-64 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 253-257 11975761-8 2002 We found that except for IgG1 anti-nucleolar antibody production and renal IgG1 deposition, other characteristics of mercury-induced autoimmunity were downregulated in SJL (H-2s) mice after chronic treatment with mercury. Mercury 213-220 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 25-29 11975761-8 2002 We found that except for IgG1 anti-nucleolar antibody production and renal IgG1 deposition, other characteristics of mercury-induced autoimmunity were downregulated in SJL (H-2s) mice after chronic treatment with mercury. Mercury 213-220 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 75-79 11529910-1 2001 In susceptible mice, the heavy metal ion mercury is able to induce a strong immune activation, which resembles a T helper 2 (Th2) type of immune response and is characterized by a polyclonal B cell activation, formation of high levels of IgG1 and IgE antibodies, production of autoantibodies of different specificities and development of renal IgG deposits. Mercury 41-48 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 238-242 11529910-5 2001 Mercury-induced IgG1 antibodies were mainly against ssDNA, TNP and thyroglobulin, but not against nucleolar antigen. Mercury 0-7 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 16-20 11529910-6 2001 Moreover, mercury-injected NOD mice developed high titres of IgG1 deposits in the kidney glomeruli. Mercury 10-17 immunoglobulin heavy constant gamma 1 (G1m marker) Mus musculus 61-65